Publications by authors named "Alan Irvine"

Claim this Profile
I
Infant palmar hyperlinearity and type 2 inflammatory markers predict atopic dermatitis at 1 year of age.
Iben Frier Ruge, Anne-Sofie Halling, Maria Rasmussen Rinnov, Trine Gerner, Mette Hjorslev Knudgaard, Alan Irvine

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triggers, Drivers, and Lids: Uncovering the Mechanistic Differentiators between IL-4- and IL-13-Targeted mAbs.
Karina M Forde, Alan D Irvine

J Invest Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of acute trauma-related pain in children and adolescents with methoxyflurane (Penthrox®) compared to placebo (MAGPIE): A randomised clinical trial.
Stuart Hartshorn, Michael J Barrett, Benjamin Bloom, Mark D Lyttle, Emily Walton, Alan Irvine

Injury· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The VASCERN-VASCA diagnostic and management pathways for kaposiform hemangioendothelioma.
Paolo Gasparella, Emir Q Haxhija, Rune Andersen, Maria Barea, Eulalia Baselga, Alan D Irvine

Eur J Pediatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P19 A rare case of PHOAR2-enteropathy syndrome (PHOAR2E; previously known as pachydermoperiostosis) with a causal variant in the SLCO2A1 gene.
Cristina Grechin, Alan D Irvine, Natasha Jordan, Bairbre Wynne

Br J Dermatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards Personalised Therapy in Chronic Spontaneous Urticaria: Advancing From Endotype to Clinical Response.
Katie Ridge, Rizwan Ahmad, Barry Moran, Cliona O'Farrelly, Jean Dunne, Alan D Irvine

Clin Exp Allergy· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks.
Alan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, Eric L Simpson, Kim A Papp

Am J Clin Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Texture of Resilience: A Darier Disease Perspective.
Fiona Sexton, Seán O'Malley, Alan D Irvine

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of upadacitinib in atopic dermatitis in randomized clinical trials across 6 years.
Christopher G Bunick, Alan D Irvine, Jonathan I Silverberg, Emma Guttman-Yassky, Mona Shahriari

J Eur Acad Dermatol Venereol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate and ciclosporin both reduce levels of circulating interleukin (IL)-4 and IL-13 expressing CD4+ memory T cells in childhood atopic dermatitis.
Anton Olsson, Kathryn Steel, Rachael Cooper, Ashley P Jones, Kaitlyn R Chan, Alan D Irvine

Clin Exp Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease.
Gerd R Burmester, Atul Deodhar, Alan D Irvine, Remo Panaccione, Kevin L Winthrop

Adv Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disproportionality analysis highlights paradoxical psoriasis as a clinically significant class effect of tumor necrosis-α inhibitors in pediatric populations.
Fiona Lynch, Alan D Irvine

Pediatr Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International multicenter case series of gestational dupilumab exposure in the treatment of atopic dermatitis: Maternal complications and fetal outcomes.
Ajay S Dulai, Emi M Murase, Gianluca Avallone, Silvia Mariel Ferrucci, Angelo Valerio Marzano, Alan D Irvine

J Am Acad Dermatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the Next Generation of In Silico Modeling of Dynamic Host-Microbiota Interactions in the Skin.
Jamie Lee, Hiu Lam Athena Wu, Ahmad A Mannan, Yuumi Nakamura, Masayuki Amagai, Alan D Irvine

JID Innov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Topical Corticosteroid Treatment on microRNA Expression in Infants with Atopic Dermatitis.
Janna Nousbeck, Maeve A McAleer, Elaine M Kenny, Alan D Irvine

JID Innov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid and Mast Cell Progenitors Are Elevated in Atopic Dermatitis.
Katie Ridge, Barry Moran, Mark A Little, Cliona O'Farrelly, Jean Dunne, Alan D Irvine

JID Innov· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Large Thymus Size at 2 Months Is Associated With Increased Risk of Atopic Dermatitis at Age 2.
Iben Frier Ruge, Maria Rasmussen Rinnov, Mie Sylow Liljendahl, Maria Zurek Munk-Madsen, Anne-Sofie Halling, Alan Irvine

Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultrastrong adhesion to human skin: Calcium as a key regulator of noncovalent interactions.
Constance Chantraine, Priscila S F C Gomes, Marion Mathelié-Guinlet, Diego E B Gomes, Zhiyong Zheng, Alan D Irvine

Sci Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementing Federated Analysis Using DataSHIELD in the DREAM TO TREAT Atopic Dermatitis Registries Collaboration.
Niels Steen Krogh, David Prieto-Merino, Bolaji Coker, Thomas Birkner, Ahmet Akkoc, Alan D Irvine

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene-environment interaction analysis in atopic eczema: evidence from large population datasets and modelling .
Marie Standl, Ashley Budu-Aggrey, Luke J Johnston, Martina S Elias, S Hasan Arshad, Alan D Irvine

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics to Treat Atopic Dermatitis: Effectiveness, Safety, and Future Directions.
Marjolein S de Bruin-Weller, Celeste M Boesjes, Roselie A Achten, Lisa A Beck, Alan D Irvine

Allergy· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caution regarding interpretation of trends for the global burden of atopic dermatitis and asthma.
Sheng-Pei Wang, Elisha Myers, Bernd W M Arents, Carsten Flohr, Alan D Irvine

Br J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024.
Nekma Meah, Jane Li, Dmitri Wall, Katherine York, Bevin Bhoyrul, Alan D Irvine

J Eur Acad Dermatol Venereol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol.
Elizaveta Gribaleva, Niels Steen Krogh, David Prieto-Merino, Bolaji Coker, Abaigeal Jackson, Alan D Irvine

Skin Health Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis